## NTRS: Northern Trust Corporation - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 0.8% below STRENGTH zone (4.0-10.0%); PEG 6.80 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($128.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Northern Trust Corporation $NTRS Shares Sold by Cerity Partners LLC**
- Source: MarketBeat | 20251208T094713 | Neutral | Relevance: 100%
-  Cerity Partners LLC reduced its holdings in Northern Trust Corporation by 4.0% in the second quarter, now owning 544,223 shares valued at $69,002,000. Despite this sale, other institutional investors like Norges Bank and Primecap Management Co. CA significantly increased their stakes. Northern Trust announced a quarterly dividend of $0.80 per share, and analysts show mixed ratings with a consensus "Hold" and target price of $132.46.

**2. Northern Trust Accelerates New Business Momentum with Institutional Asset Owners in 2025**
- Source: Stock Titan | 20251209T100304 | Bullish | Relevance: 99%
-  Northern Trust (Nasdaq: NTRS) announced significant new business growth in 2025, securing over 100 mandates from institutional asset owners globally, totaling more than US$385 billion in assets under custody. This success underscores their strategic partnership approach and continuous investment in client-focused solutions, including Front Office Solutions, Integrated Trading Solutions, and OCIO Services. The company emphasizes its commitment to empowering clients' missions through innovation and service excellence.

**3. Northern Trust Corporation $NTRS Shares Sold by Amundi**
- Source: MarketBeat | 20251209T081141 | Neutral | Relevance: 97%
-  Amundi significantly reduced its stake in Northern Trust Corporation (NTRS) by 58.9% in Q2, selling over 800,000 shares. Despite this, Northern Trust slightly beat earnings estimates and offers a 2.4% dividend yield, while analysts currently rate the stock as a "Hold" with an average target price of $132.46.

**4. Gamco Investors INC. ET AL Sells 8,106 Shares of Northern Trust Corporation $NTRS**
- Source: MarketBeat | 20251208T114537 | Neutral | Relevance: 96%
-  Gamco Investors INC. ET AL has reduced its stake in Northern Trust Corporation (NASDAQ:NTRS) by 4.4% in the second quarter, selling 8,106 shares and ending the period with 176,740 shares valued at approximately $22.41 million. Despite this, other institutions have largely increased their positions, maintaining institutional ownership at about 83.19%. The company has also announced a quarterly dividend of $0.80, and analysts currently hold a consensus "Hold" rating with an average price target of $132.46.

**5. JPMorgan Chase & Co. Has $11.75 Million Position in Aegon NV $AEG**
- Source: MarketBeat | 20251208T101023 | Neutral | Relevance: 62%
- JPMorgan Chase & Co. significantly increased its stake in Aegon NV by 1,073.4% in Q2, acquiring an additional 1,485,135 shares to hold 1,623,496 shares valued at approximately $11.75 million. Other institutional investors also raised their positions, with institutions now owning about 4.32% of Aegon's stock. Despite mixed analyst ratings, the consensus is a "Moderate Buy" for Aegon, which recently traded around $7.82 with a market cap of $15.69 billion.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 15 ($0.74M) |
| Sells | 11 ($1.57M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-1.3%)
- FMR, LLC: 8.3% (-9.9%)
- Blackrock Inc.: 7.9% (-1.4%)
- State Street Corpora: 5.0% (+1.0%)
- Primecap Management : 4.0% (-3.2%)

### Key Risks

1. Valuation stretched: PEG 6.8x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 6.80 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 22%). Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $25.4B |
| Beta | 1.28 |
| 52W Range | $81.62 - $135.48 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 6.80 |
| Forward P/E | 14.3 |
| Current P/E | 15.5 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.6% over 5 days). Below STRENGTH zone by 3.2pp (needs >4.0% for momentum thesis). MRS_5 at 0.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.54), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.76% (CS: 65) | Neutral |
| RSI_14 | 62.4 | Neutral |
| MACD Histogram | 0.54 | Bullish |
| vs SMA20 | 1.029x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 1.138x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $133.38
- **Stop Loss:** $128.22 (3.9% risk)
- **Target:** $138.54 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 96
- **Position Value:** $12,804.48
- **Portfolio %:** 12.80%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-22 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.24 | $2.29 | +2.2% |
| 2025Q2 | $2.04 | $2.13 | +4.2% |
| 2025Q1 | $1.84 | $1.90 | +3.1% |
| 2024Q4 | $2.00 | $2.26 | +12.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*